Crinetics Ready To Launch First Once-Daily Oral Acromegaly Drug, Palsonify

Paltusotine Also In Phase III For Carcinoid Syndrome

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.